Scientists create potent 'degrader' of cancer-driving protein
Scientists at The Institute of Cancer Research, London, have created a compound that destroys a protein involved in driving cancers, including B-cell lymphoma.
Scientists at The Institute of Cancer Research, London, have created a compound that destroys a protein involved in driving cancers, including B-cell lymphoma.
Biochemistry
Apr 26, 2023
0
51
To develop cancer drugs, researchers often have to make tough trade-offs. Most drugs potent enough to kill tumors also cause unpleasant side effects—and may end up doing more harm than good. Now, researchers and clinicians ...
Bio & Medicine
Apr 26, 2023
0
89
LMU researchers have discovered a weakness in the bacterium Helicobacter pylori, which could be exploited to develop new drugs.
Cell & Microbiology
Apr 26, 2023
0
12
An MUSC Hollings Cancer Center research team has identified a protein that helps cancer cells to organize themselves in a way that allows them to successfully navigate the cell division process despite an abnormality that ...
Cell & Microbiology
Apr 25, 2023
0
23
Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer—one of the most aggressive and difficult to treat cancers—by delivering immunotherapy directly into the tumor with a device that is ...
Bio & Medicine
Apr 13, 2023
0
1802
EPFL researchers have used a nanoplasmonics approach to observe the real-time production of cell secretions, including proteins and antibodies; an advancement that could aid in the development of cancer treatments, vaccines, ...
Bio & Medicine
Apr 11, 2023
0
42
An ideal nanovesicle to fight cancer would have three functionalities: 1) a precision-targeting molecule to preferentially bind it to surface markers on cancer cells, 2) a strongly bound radionuclide signal that would allow ...
Bio & Medicine
Apr 10, 2023
0
72
A research team co-led by chemists from City University of Hong Kong (CityU) recently discovered novel, highly effective anticancer agents with tridimensional structures, which have high anticancer activity, low toxicity ...
Biochemistry
Apr 6, 2023
0
18
Anticancer drugs are pivotal to cancer treatment, but their toxicity may not always be limited to cancer cells, resulting in harmful side-effects. To develop anticancer therapies that have fewer adverse effects on patients, ...
Biochemistry
Apr 3, 2023
0
11
Shigella bacteria can infect humans but not mice. In the March 29 issue of Nature, a team from UConn Health explains why. Their findings may explain the multifariousness of a key weapon of our immune system.
Cell & Microbiology
Mar 30, 2023
0
20